Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility

Clinical Infectious Diseases

Volumn 71, Issue 9, 2020, Pages 2428-2446

  Chan, Jasper Fuk Woo ^a,b,c   Zhang, Anna Jinxia ^a   Yuan, Shuofeng ^a   Poon, Vincent Kwok Man ^a   Chan, Chris Chung Sing ^a   Lee, Andrew Chak Yiu ^a   Chan, Wan Mui ^a   Fan, Zhimeng ^a   Tsoi, Hoi Wah ^a   Wen, Lei ^a   Liang, Ronghui ^a   Cao, Jianli ^a   Chen, Yanxia ^a   Tang, Kaiming ^a   Luo, Cuiting ^a   Cai, Jian Piao ^a   Kok, Kin Hang ^a   Chu, Hin ^a   Chan, Kwok Hung ^a   Sridhar, Siddharth ^a,b,c   Chen, Zhiwei ^a   Chen, Honglin ^a   To, Kelvin Kai Wang ^a,b,c   Yuen, Kwok Yung ^a,b,c   more..

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG SHENZHEN HOSPITAL   (China)

^c QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

animal; coronavirus; COVID 19; SARS CoV 2; transmission

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; CHEMOKINE; CORONAVIRUS NUCLEOCAPSID PROTEIN; CYTOKINE; VIRUS SPIKE PROTEIN; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; APOPTOSIS; ARTICLE; BINDING AFFINITY; CLINICAL FEATURE; CORONAVIRUS DISEASE 2019; FEMALE; HISTOPATHOLOGY; IMMUNOPROPHYLAXIS; MALE; MAMMAL; MOLECULAR DOCKING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYRIAN HAMSTER; TISSUE REPAIR; TROPISM; VIRUS ISOLATION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION; ANIMAL; BLOOD; DISEASE MODEL; HAMSTER; IMMUNOLOGY; LUNG; PATHOLOGY; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; COVID-19; CRICETINAE; DISEASE MODELS, ANIMAL; LUNG; MOLECULAR DOCKING SIMULATION; SARS-COV-2; VIRAL LOAD;

EID: 85083116424     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciaa325     Document Type: Article

References (35)

1. Zhu N, Zhang D, Wang W, et al; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382:727-33.
2. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395:514-23.
3. Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 2020; 9:221-36.
4. Channel News Asia. South Korea's coronavirus cases climb above 7, 000, most cases traced to church. March 7, 2020. Available at: https://www.channelnewsasia. com/news/asia/south-korea-s-coronavirus-cases-climb-above-7-000-mostcases- 12512784. Accessed 9 March 2020.
5. Rocklov J, Sjodin H, Wilder-Smith A. COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures. J Travel Med 2020. doi: 10.1093/jtm/taaa030. [Epub ahead of print].
6. Kamp J. Coronavirus spreads to more elder facilities in Seattle area. The Wall Street Journal. March 10, 2020. Available at: https://www.wsj.com/articles/ coronavirus-spreads-to-more-elder-facilities-in-seattle-area-11583884557. Accessed 10 March 2020.
7. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. Epub ahead of print. doi: 10.1001/jama.2020.1585
8. World Health Organization. Coronavirus disease (COVID-2019) situation report-49. March 9, 2020. Available at: https://www.who.int/docs/ default-source/coronaviruse/situation-reports/20200309-sitrep-49-covid-19. pdf?sfvrsn=70dabe61-4. Accessed 9 March 2020.
9. Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA 2020. doi: 10.1001/ jama.2020.2131. [Epub ahead of print].
10. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020. doi: 10.1056/NEJMoa2002032. [Epub ahead of print].
11. Callaway E. How monkeys, mice and ferrets are helping scientists to fight coronavirus. Nature 2020. Available at: https://www.nature.com/articles/d41586-020- 00698-x. Accessed 9 March 2020.
12. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004; 32:1792-7.
13. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 2008; 9:40.
14. Das R, Baker D. Macromolecular modeling with Rosetta. Annu Rev Biochem 2008; 77:363-82.
15. Chan JF, Yip CC, To KK, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J Clin Microbiol 2020. doi: 10.1128/JCM.00310-20. [Epub ahead of print].
16. Chan JF, Zhang AJ, Chan CC, et al. Zika virus infection in dexamethasoneimmunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons. EBioMedicine 2016; 14:112-22.
17. Espitia CM, Zhao W, Saldarriaga O, et al. Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis. BMC Immunol 2010; 11:31.
18. To KK, Tsang OT, Leung WS, et al. Temporal profiles of deep throat saliva viral load and serum antibody response during COVID-19 infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020. pii: S1473-3099(20)30196-
19. Epub ahead of print. doi: 10.1016/S1473-3099(20)30196-1.
20. Julander JG, Testori M, Cheminay C, Volkmann A. Immunogenicity and protection after vaccination with a modified Vaccinia virus Ankara-vectored yellow fever vaccine in the hamster model. Front Immunol 2018; 9:1756.
21. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497-506.
22. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020. doi: 10.1016/ S2213-2600(20)30076-X. [Epub ahead of print].
23. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395:507-13.
24. Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis 2020. doi: 10.1016/S1473-3099(20)30113-4. [Epub ahead of print].
25. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020. doi: 10.1007/s00134-020-05991-x. [Epub ahead of print].
26. Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 2007; 20:660-94.
27. Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen KY. Middle East respiratory syndrome coronavirus: another zoonotic beta Coronavirus causing SARS-like disease. Clin Microbiol Rev 2015; 28:465-522.
28. Cheng VC, To KK, Tse H, Hung IF, Yuen KY. Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev 2012; 25:223-63.
29. Liu L, Wei Q, Lin Q, et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight 2019; 4.
30. Grant K. Rodent nutrition: digestive comparisons of 4 common rodent species. Vet Clin North Am Exot Anim Pract 2014; 17:471-83.
31. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579:270-3.
32. Roberts A, Vogel L, Guarner J, et al. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol 2005; 79:503-11.
33. Miao J, Chard LS, Wang Z, Wang Y. Syrian hamster as an animal model for the study on infectious diseases. Front Immunol 2019; 10:2329.
34. Iwatsuki-Horimoto K, Nakajima N, Ichiko Y, et al. Syrian hamster as an animal model for the study of human influenza virus infection. J Virol 2018; 92.
35. Tollefson AE, Ying B, Spencer JF, Sagartz JE, Wold WSM, Toth K. Pathology in permissive Syrian hamsters after infection with species C human adenovirus (HAdV-C) is the result of virus replication: HAdV-C6 replicates more and causes more pathology than HAdV-C5. J Virol 2017; 91.